Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors

Human Pathology

Volumn 35, Issue 7, 2004, Pages 857-861

  Xu, H ^b   Edwards, J R ^b   Espinosa, O ^b   Banerji, S ^b   Jackson, D G ^b   Athanasou, N A ^a  

^a NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^b NONE

Author keywords

angiosarcoma; endothelial cell; factor VIII RAg; factor VIII related antigen; lymphatics; LYVE 1; vascular endothelial growth factor receptor; VEGFR

Indexed keywords

CELL MARKER; HYALURONAN RECEPTOR; HYALURONIC ACID; RECEPTOR; UNCLASSIFIED DRUG;

ANGIOSARCOMA; ARTICLE; BENIGN TUMOR; CAPILLARY HEMANGIOMA; CAVERNOUS HEMANGIOMA; ENDOTHELIUM CELL; GLOMUS TUMOR; HEMANGIOMA; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; KAPOSI SARCOMA; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PROTEIN EXPRESSION; PYOGENIC GRANULOMA; VASCULAR TUMOR;

ENDOTHELIUM, LYMPHATIC; GLYCOPROTEINS; HEMANGIOSARCOMA; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASMS, VASCULAR TISSUE; SARCOMA, KAPOSI; TUMOR MARKERS, BIOLOGICAL;

EID: 3142562326     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.02.009     Document Type: Article

References (25)

1. Fletcher C.D., Unni K.K., Mertens F. World Health Organization Classification of Tumors Tumors of Soft Tissue and Bone. 2002;IARC Press, Lyon, France
2. Weiss S.W., Goldblum J.R. Enzinger and Weiss's Soft Tissue Tumors. 2001;Mosby, St. Louis, MO
3. Breiteneder-Geleff S., Soleiman A., Kowalski H., et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 154:1999;385-394
4. Folpe A.L., Veikkola T., Valtola R., et al. Vascular endothelial growth factor receptor-3 (VEGFR-3) A marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol. 13:2000;180-185
5. Lymboussaki A., Partanen T.A., Olofsson B., et al. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol. 153:1998;395-403
6. Partanen T.A., Alitalo K., Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer. 86:1999;2406-2412
7. Banerji S., Ni V., Wang S.X., et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 144:1999;789-801
8. Kempson R.L., Fletcher C.D., Evans H.L., et al. Atlas of Tumor Pathology Tumors of the Soft Tissues, Third series, Fascicle 30. 2001;Armed Forces Institute of Pathology, Washington, DC
9. Jackson D.G., Prevo R., Clasper S., et al. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol. 22:2001;317-321
10. Aruffo A., Stamenkovic I., Melnick M., et al. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1990;1303-1313
11. Prevo R., Banerji S., Ferguson D.J., et al. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem. 276:2001;19420-19430
12. Turner R.R., Beckstead J.H., Warhke R.A., et al. Endothelial cell phenotypic diversity In situ demonstration of immunologic and enzymatic heterogeneity that correlates with specific morphologic subtypes. Am J Clin Pathol. 87:1987;569-575
13. Hultberg B.M., Svanholm H. Immunohistochemical differentiation between lymphangiographically vertified lymphatic vessels and blood vessels. Virchows Archiv. 414:1989;209-215
14. Romani P., Shah A. Lymphangiomatosis Histological and immunohistochemical analysis of four cases. Am J Surg Pathol. 17:1993;. 329-325
15. Sauter B., Foedinger D., Sterniczky B., et al. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytockem. 46:1998;165-176
16. Kaipainen A., Korhonen J., Mustonen T., et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A. 92:1995;3566-3570
17. Kukk E., Lymboussallis A., Taira S., et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development. 122:1996;. 3829-3827
18. Rodriguez-Niedenfuhr M., Papoutsi M., Christ B., et al. Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol. 204:2001;399-406
19. Wigle J.T., Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 98:1999;769-778
20. Sleeman J.P., Krishnan J., Kirkin V., et al. Markers for the lymphatic endothelium In search of the holy grail? Microsc Res Tech. 55:2001;61-69
21. Jeltsch M., Kaipanen A., Joukov V., et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 276:1997;1423-1425
22. Ohsawa M., Naka N., Tomita Y., et al. Use of immunohistochemical procedures in diagnosing angiosarcoma. Evaluation of 98 cases. Cancer. 75:1995;2867-2874
23. Poblet E., Gonzalez-Palacios F., Jimenez F.J. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas. Virchows Arch. 428:1996;217-221
24. Oliver G., Detmar M. The rediscovery of the lymphatic system Old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 16:2002;773-783
25. Requena L., Sangueza O.P. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms. J Am Acad Dermatol. 37:1997;887-919